JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rizvanov, A. A.
Right arrow Articles by St. Jeor, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizvanov, A. A.
Right arrow Articles by St. Jeor, S. C.
Journal of Virology, November 2003, p. 12203-12210, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.12203-12210.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Generation of a Recombinant Cytomegalovirus for Expression of a Hantavirus Glycoprotein

Albert A. Rizvanov,1,2 Albert G. M. van Geelen,1,{dagger} Sergey Morzunov,1,3 Elmer W. Otteson,1 Charlotte Bohlman,1,2 Gregory S. Pari,1,2 and Stephen C. St. Jeor1,2*

Department of Microbiology,1 Graduate Program in Cell and Molecular Biology, University of Nevada at Reno,2 Department of Pathology and Nevada State Health Laboratory, Reno, Nevada 895573

Received 14 May 2003/ Accepted 29 July 2003

A cytomegalovirus (CMV) was isolated from its natural host, Peromyscus maniculatus, and was designated Peromyscus CMV (PCMV). A recombinant PCMV was constructed that contained Sin Nombre virus glycoprotein G1 (SNV-G1) fused in frame to the enhanced green fluorescent protein (EGFP) gene inserted into a site homologous to the human CMV UL33 (P33) gene. The recombinant CMV was used for expression and immunization of deer mice against SNV-G1. The results of the study indicate that P. maniculatus could be infected with as few as 10 virus particles of recombinant virus. Challenge of P. maniculatus with either recombinant or wild-type PCMV produced no overt pathology in infected animals. P. maniculatus immunized with recombinant virus developed an antibody response to SNV and EGFP. When rechallenged with recombinant virus, animals exhibited an anamnestic response against SNV. Interestingly, a preexisting immune response against PCMV did not prevent reinfection with recombinant PCMV.


* Corresponding author. Mailing address: Department of Microbiology, Graduate Program in Cell and Molecular Biology, University of Nevada, Reno, NV 89557. Phone: (775) 784-6161. Fax: (775) 327-2332. E-mail: stjeor{at}med.unr.edu.

{dagger} Present address: University of California at Davis, Center for Comparative Medicine, Davis, CA 95616.


Journal of Virology, November 2003, p. 12203-12210, Vol. 77, No. 22
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.22.12203-12210.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.